Covalon Technologies (OTCMKTS:CVALF) Stock Price Down 1.9%

Covalon Technologies Ltd. (OTCMKTS:CVALF) shares fell 1.9% on Friday . The stock traded as low as $0.80 and last traded at $0.80. 3,700 shares were traded during trading, a decline of 32% from the average session volume of 5,413 shares. The stock had previously closed at $0.82.

Covalon Technologies Stock Performance

The stock has a market cap of $20.06 million, a P/E ratio of -5.33 and a beta of -0.56. The company’s 50 day moving average price is $0.87 and its 200-day moving average price is $0.89.

Covalon Technologies (OTCMKTS:CVALF) last posted its earnings results on Wednesday, February 28th. The company reported ($0.02) earnings per share (EPS) for the quarter. Covalon Technologies had a negative return on equity of 23.88% and a negative net margin of 19.70%. The firm had revenue of $3.43 million during the quarter.

Covalon Technologies Company Profile

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally. The company's platform technologies comprise collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; and antimicrobial silicone adhesive platform, which is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad-spectrum antimicrobial activity.